Dimaymay, Jenifer .
HRN: 06-29-02 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/23/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/23/2024
07/30/2024
IV
500 Mg
Q8
UTI X 3 Doses
Waiting Final Action
Indication: Prophylaxis Type of Infection: Urinary TractReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes